JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
RNAC - Cartesian Therapeutics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary RNAC Stock
Financials
Financials RNAC Stock
Loading...
Loading...
Income Statement
Income Statement RNAC Stock
Balance Sheet
Balance Sheet RNAC Stock
Cash Flow Statement
Cash Flow Statement RNAC Stock
Loading...
Loading...
RNAC Financials - Cartesian Therapeutics Income & Cash Flow | Ledgeburg
Home
Stocks
Cartesian Therapeutics, Inc. (RNAC)
Financials
Financials of RNAC
Loading...
Loading...
Loading...
Loading...
Revenue
$2.797M
Operating Income
$-143.405M
Net Income
$-130.302M
Share Count (Basic)
25.973329M
Operating Cash Flow
$-73.941M
Free Cash Flow
$-79.395M
Cash And Short-Term Equivalents
$125.139M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
20M
40M
60M
80M
100M
120M
FY2021
FY2022
Revenue $USD
0
200K
400K
600K
800K
1M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Annual
Quarterly
Net Income $USD
-200M
-150M
-100M
-50M
0
Annual
Quarterly
Margins
Gross
Operating
Net
-4000%
-2000%
0%
FY2023
FY2024
FY2025
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-100M
-80M
-60M
-40M
-20M
0
20M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-40000%
-20000%
0%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26